Agilent Technologies, Inc. - Diagnostics and Genomics SSXT2 CD GlasgowCancerCore, 96
The Agilent SureSelectXT2 CD GlasgowCancerCore, 96 is a targeted enrichment solution designed for next-generation sequencing (NGS) applications. This kit enables the capture and enrichment of specific genomic regions associated with cancer research, supporting high-throughput workflows with a 96-reaction format. The SureSelectXT2 technology provides high specificity and uniformity in target enrichment, facilitating accurate variant detection and comprehensive genomic profiling. It is optimized for use with Illumina sequencing platforms and is suitable for laboratories conducting cancer genomics studies requiring reliable and reproducible results.